XWELL Price to Book Ratio 2012-2026 | XWEL
Historical price to book ratio values for XWELL (XWEL) over the last 10 years. The current price to book ratio for XWELL as of September 16, 2026 is 0.92.
| XWELL Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2026-09-16 | 0.91 | 0.93 | |
| 2026-06-30 | 1.04 | $0.97 | 1.07 |
| 2026-03-31 | 1.15 | $1.27 | 0.90 |
| 2025-12-31 | 0.46 | $-2.11 | -0.22 |
| 2025-09-30 | 0.99 | $0.53 | 1.86 |
| 2025-06-30 | 0.92 | $0.71 | 1.30 |
| 2025-03-31 | 1.02 | $0.54 | 1.88 |
| 2024-12-31 | 1.51 | $1.47 | 1.03 |
| 2024-09-30 | 1.73 | $2.82 | 0.61 |
| 2024-06-30 | 1.80 | $4.12 | 0.44 |
| 2024-03-31 | 1.69 | $4.49 | 0.38 |
| 2023-12-31 | 1.74 | $5.02 | 0.35 |
| 2023-09-30 | 2.25 | $6.53 | 0.34 |
| 2023-06-30 | 4.00 | $8.87 | 0.45 |
| 2023-03-31 | 7.20 | $10.22 | 0.70 |
| 2022-12-31 | 7.20 | $11.52 | 0.62 |
| 2022-09-30 | 15.40 | $14.78 | 1.04 |
| 2022-06-30 | 13.80 | $16.77 | 0.82 |
| 2022-03-31 | 22.60 | $18.47 | 1.22 |
| 2021-12-31 | 40.40 | $19.74 | 2.05 |
| 2021-09-30 | 29.40 | $19.73 | 1.49 |
| 2021-06-30 | 30.80 | $17.75 | 1.73 |
| 2021-03-31 | 36.80 | $18.60 | 1.98 |
| 2020-12-31 | 23.80 | $17.09 | 1.39 |
| 2020-09-30 | 39.40 | $16.90 | 2.33 |
| 2020-06-30 | 83.80 | $10.50 | 7.98 |
| 2020-03-31 | 11.40 | $-4.02 | -2.84 |
| 2019-12-31 | 40.20 | $-9.84 | -4.09 |
| 2019-09-30 | 86.40 | $93.30 | 0.93 |
| 2019-06-30 | 116.40 | $212.74 | 0.55 |
| 2019-03-31 | 144.00 | $340.84 | 0.42 |
| 2018-12-31 | 192.00 | $447.32 | 0.43 |
| 2018-09-30 | 180.00 | $592.35 | 0.30 |
| 2018-06-30 | 348.00 | $797.22 | 0.44 |
| 2018-03-31 | 864.00 | $991.99 | 0.87 |
| 2017-12-31 | 1644.00 | $2,072.81 | 0.79 |
| 2017-09-30 | 1668.00 | $2,524.77 | 0.66 |
| 2017-06-30 | 1980.00 | $3,266.38 | 0.61 |
| 2017-03-31 | 2604.00 | $3,771.83 | 0.69 |
| 2016-12-31 | 2556.00 | $4,207.07 | 0.61 |
| 2016-09-30 | 3228.00 | $2,029.80 | 1.59 |
| 2016-06-30 | 2268.00 | $2,375.46 | 0.95 |
| 2016-03-31 | 1968.00 | $3,203.20 | 0.61 |
| 2015-12-31 | 2964.00 | $3,678.07 | 0.81 |
| 2015-09-30 | 6720.00 | $1,811.89 | 3.71 |
| 2015-06-30 | 6720.00 | $2,551.16 | 2.63 |
| 2015-03-31 | 7800.00 | $3,366.89 | 2.32 |
| 2014-12-31 | 6600.00 | $4,006.40 | 1.65 |
| 2014-09-30 | 11400.00 | $13,513.86 | 0.84 |
| 2014-06-30 | 41040.00 | $14,804.84 | 2.77 |
| 2014-03-31 | 41640.00 | $15,258.88 | 2.73 |
| 2013-12-31 | 35520.00 | $16,230.44 | 2.19 |
| 2013-09-30 | 34440.00 | $18,559.41 | 1.86 |
| 2013-06-30 | 38040.00 | $19,630.45 | 1.94 |
| 2013-03-31 | 38040.00 | $20,318.57 | 1.87 |
| 2012-12-31 | 34440.00 | $21,738.72 | 1.58 |
| 2012-09-30 | 34800.00 | $16,686.31 | 2.09 |
| 2012-06-30 | 46320.00 | $-0.09 | -507894.74 |
| 2012-03-31 | 19800.00 | $0.07 | 268656.72 |
| 2011-12-31 | 11880.00 | $0.28 | 43184.30 |
| 2011-09-30 | 17040.00 | $-0.55 | -30919.98 |
| 2011-06-30 | 14640.00 | $-0.29 | -49762.07 |
| 2011-03-31 | 20400.00 | $-0.16 | -126472.41 |
| 2010-12-31 | 28560.00 | $-0.04 | -644695.26 |
| 2010-09-30 | 39600.00 | $0.01 | 2657718.12 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.008B | $0.029B |
| XWELL Inc. is a health and wellness holding company. Its operating brands include XpresCheck(R), XpresSpa(R), Treat(TM) and HyperPointe. XpresSpa is a retailer of wellness services and related products. Treat is a travel health and wellness brand. XpresCheck is a provider of Covid-19 screening and diagnostic testing in partnership with the CDC and Concentric by Ginkgo. HyperPointe is a digital healthcare and data analytics relationship company. XWELL Inc., formerly known as XpresSpa Group Inc., is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $147.177B | 25.78 |
| CVS Health (CVS) | United States | $120.850B | 12.05 |
| HCA Healthcare (HCA) | United States | $91.758B | 14.27 |
| Elevance Health (ELV) | United States | $90.552B | 14.21 |
| Cencora (COR) | United States | $61.693B | 18.85 |
| Natera (NTRA) | United States | $50.563B | 0.00 |
| Labcorp Holdings (LH) | United States | $26.274B | 18.52 |
| Viatris (VTRS) | United States | $19.124B | 6.61 |
| Medpace Holdings (MEDP) | United States | $17.319B | 36.37 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $16.369B | 0.00 |
| DiDi Global (DIDIY) | China | $16.046B | 176.00 |
| Revvity (RVTY) | United States | $15.643B | 26.20 |
| Solventum (SOLV) | United States | $15.330B | 12.69 |
| ICON (ICLR) | Ireland | $13.204B | 17.94 |
| Charles River Laboratories (CRL) | United States | $13.027B | 27.56 |
| BrightSpring Health Services (BTSG) | United States | $11.642B | 40.03 |
| Avantor (AVTR) | United States | $10.443B | 18.83 |
| BioMerieux (BMXMF) | France | $10.192B | 0.00 |
| Caris Life Sciences,�Inc (CAI) | United States | $8.054B | 79.17 |
| HealthEquity (HQY) | United States | $7.983B | 26.01 |
| Sonic Healthcare (SKHHY) | Australia | $6.771B | 0.00 |
| PACS (PACS) | United States | $6.662B | 22.39 |
| GETINGE (GNGBY) | Sweden | $6.654B | 18.79 |
| CochLear (CHEOY) | Australia | $6.327B | 0.00 |
| MiniMed (MMED) | United States | $6.193B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.157B | 23.28 |
| Sotera Health (SHC) | United States | $5.416B | 22.33 |
| Concentras Parent (CON) | United States | $4.542B | 22.40 |
| Organon (OGN) | United States | $3.587B | 4.55 |
| GeneDx Holdings (WGS) | United States | $2.822B | 262.89 |
| CareDx (CDNA) | United States | $2.723B | 309.65 |
| Amplifon S.p.A (AMFPF) | Italy | $2.466B | 12.74 |
| Pediatrix Medical (MD) | United States | $2.169B | 12.71 |
| Alignment Healthcare (ALHC) | United States | $2.151B | 54.58 |
| Establishment Labs Holdings (ESTA) | United States | $2.130B | 0.00 |
| Progyny (PGNY) | United States | $2.130B | 30.17 |
| COMPASS Pathways (CMPS) | United Kingdom | $1.912B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $1.907B | 0.00 |
| Surgery Partners (SGRY) | United States | $1.787B | 68.25 |
| Bora Pharmaceuticals, - (BORAY) | Taiwan | $1.695B | 10.18 |
| Freenome (FRNM) | United States | $1.573B | 0.00 |
| Agilon Health (AGL) | United States | $1.547B | 0.00 |
| Ardent Health (ARDT) | United States | $1.508B | 8.62 |
| InnovAge Holding (INNV) | United States | $1.490B | 0.00 |
| Nutex Health (NUTX) | United States | $1.475B | 8.45 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.241B | 0.00 |
| Omada Health (OMDA) | United States | $1.204B | 245.88 |
| GoodRx Holdings (GDRX) | United States | $1.196B | 23.27 |
| Teladoc Health (TDOC) | United States | $1.195B | 0.00 |
| CryoPort (CYRX) | United States | $0.826B | 0.00 |
| Enhabit (EHAB) | United States | $0.709B | 25.89 |
| GMR Solutions (GMRS) | United States | $0.688B | 0.00 |
| Oncology Institute (TOI) | United States | $0.507B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.504B | 0.00 |
| SBC Medicals (SBC) | United States | $0.472B | 9.77 |
| Strata Critical Medical (SRTA) | United States | $0.468B | 0.00 |
| Forward Industries (FWDI) | United States | $0.449B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.382B | 5.55 |
| Shoulder Innovations (SI) | United States | $0.374B | 0.00 |
| Biodesix (BDSX) | United States | $0.292B | 0.00 |
| Embecta (EMBC) | United States | $0.288B | 2.50 |
| So-Young (SY) | China | $0.276B | 0.00 |
| LifeMD (LFMD) | United States | $0.164B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.107B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.098B | 0.00 |
| SkinHealth Systems (SKIN) | United States | $0.088B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.079B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.068B | 8.06 |
| Tevogen (TVGN) | United States | $0.050B | 0.00 |
| DocGo (DCGO) | United States | $0.038B | 0.00 |
| Lifeward (LFWD) | United States | $0.020B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.013B | 0.00 |
| Ainos (AIMD) | United States | $0.010B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.008B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.008B | 0.00 |
| Aclarion (ACON) | United States | $0.008B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| 20/20 Biolabs (AIDX) | United States | $0.006B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| Pomdoctor - (POM) | China | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.004B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |